(Q40791618)

23 September 2017

1 reference

title

Present status and future prospects of oral iron chelation therapy in thalassaemia and other diseases (English)

1 reference

23 September 2017

0 references

G J Kontoghiorghes

1

1 reference

23 September 2017

language of work or name

1 reference

1 July 1993

1 reference

Indian Journal of Pediatrics

23 September 2017

published in

1 reference

23 September 2017

volume

60

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

485-507

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02751425

23 September 2017

exact match

0 references

cites work

Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02751425

The study of iron mobilisation from transferrin using alpha-ketohydroxy heteroaromatic chelators

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02751425

Thrombocytopenia associated with intravenous desferrioxamine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02751425

Animal toxicology of iron chelator L1

21 January 2018

1 reference

12 December 2020

Oral iron chelation is here

1 reference

12 December 2020

Clinical management of thalassemia. The status of new iron chelators

1 reference

12 December 2020

Impaired erythropoietin responsiveness to the anaemia in rheumatoid arthritis. A possible inverse relationship with iron stores and effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one

1 reference

12 December 2020

Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

1 reference

12 December 2020

Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions

1 reference

12 December 2020

Iron absorption and transport in microorganisms

1 reference

12 December 2020

Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits

1 reference

12 December 2020

Advances in oral iron chelation in man

1 reference

12 December 2020

Long-term trial with the oral iron chelator 1, 2-dimethyl-3-hydroxypyrid-4-one (L1). I. Iron chelation and metabolic studies

1 reference

12 December 2020

Survival and causes of death in thalassaemia major

1 reference

12 December 2020

Chelators affecting iron absorption in mice

1 reference

12 December 2020

Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients.

1 reference

12 December 2020

The effect of synthetic iron chelators on bacterial growth in human serum

1 reference

12 December 2020

Pyridoxal isonicotinoyl hydrazone: an effective iron-chelator after oral administration

1 reference

12 December 2020

Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals

1 reference

12 December 2020

Community control of hereditary anaemias: memorandum from a WHO meeting

1 reference

12 December 2020

Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritis

1 reference

12 December 2020

Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia

1 reference

12 December 2020

Cardioxane--ICRF-187 towards anticancer drug specificity through selective toxicity reduction

1 reference

12 December 2020

In Vitro Screening of Iron Chelators Using Models of Free Radical Damage

1 reference

12 December 2020

Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis).

1 reference

12 December 2020

Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA).

1 reference

12 December 2020

New synthetic approach and iron chelating studies of 1-alkyl-2-methyl-3-hydroxypyrid-4-ones

1 reference

12 December 2020

Cytotoxic effects of the lipophilic iron chelator omadine

1 reference

12 December 2020

Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats

1 reference

12 December 2020

Desferrioxamine suppositories

1 reference

12 December 2020

Drug-induced agranulocytosis

1 reference

12 December 2020

Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant

1 reference

12 December 2020

Treatment of rheumatoid arthritis with desferrioxamine: relation between stores of iron before treatment and side effects

1 reference

12 December 2020

Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions

1 reference

12 December 2020

Calcium Disodium Edta in Transfusion Hemosiderosis

1 reference

12 December 2020

Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

1 reference

12 December 2020

1 reference

12 December 2020

Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia

1 reference

12 December 2020

Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one

1 reference

12 December 2020

Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients

1 reference

12 December 2020

Pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine infusions

1 reference

12 December 2020

Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload

1 reference

12 December 2020

Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes

1 reference

12 December 2020

Iron chelation with oral desferrioxamine

1 reference

12 December 2020

Oral iron chelation with L1

1 reference

12 December 2020

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Future of oral iron chelator deferiprone. (L1) ICOC committee

1 reference

12 December 2020

A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine

1 reference

12 December 2020

Orally active alpha-ketohydroxypyridine iron chelators: studies in mice

1 reference

12 December 2020

In vitro and in vivo effects of deferoxamine in neonatal acute leukemia

1 reference

12 December 2020

Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major

1 reference

12 December 2020

Antimalarial properties of orally active iron chelators.

1 reference

12 December 2020

Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice

1 reference

12 December 2020

Prospects for effective oral iron chelation therapy in man with 1,2-dimethyl-3-hydroxypyrid-4-one and other alpha-ketohydroxypyridines

1 reference

12 December 2020

Orally active alpha-ketohydroxypyridine iron chelators: effects on iron and other metal mobilisations

1 reference

12 December 2020

Intramuscular desferrioxamine in patients with Alzheimer's disease

1 reference

12 December 2020

1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload

1 reference

12 December 2020

Development of oral iron chelator L1

1 reference

12 December 2020

Chelation studies with 2,3-dihydroxybenzoic acid in patients with beta-thalassaemia major

1 reference

12 December 2020

An evaluation of the potential of HBED as an orally effective iron-chelating drug

1 reference

12 December 2020

Toxicity of oral iron chelator L1

1 reference

12 December 2020

Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial

1 reference

12 December 2020

L1 (1,2-dimethyl-3-hydroxypyrid-4-one) for oral iron chelation in patients with beta-thalassaemia major

1 reference

12 December 2020

Rhodotorulic acid--investigation of its potential as an iron-chelating drug

1 reference

12 December 2020

Syntheses of iron bis(pyridoxal isonicotinoylhydrazone)s and the in vivo iron-removal properties of some pyridoxal derivatives

1 reference

12 December 2020

Design, properties, and effective use of the oral chelator L1 and other alpha-ketohydroxypyridines in the treatment of transfusional iron overload in thalassemia

1 reference

12 December 2020

Dose response studies using desferrioxamine and orally active chelators in a mouse model

1 reference

12 December 2020

Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts

1 reference

12 December 2020

Iron mobilisation from lactoferrin by chelators at physiological pH

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02751425

1 reference

23 September 2017

1 reference